BIOMAT Database Logo BIOMAT Database Logo

Hypereosinophilic dermatosis: skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome? 2000

A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi

UI MeSH Term Description Entries
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017681 Hypereosinophilic Syndrome A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs. Endocarditis, Loeffler's,Idiopathic Hypereosinophilic Syndrome,Leukemia, Eosinophilic,Loeffler's Endocarditis,Endocarditis, Loeffler,Hypereosinophilic Syndrome, Idiopathic,Loeffler Endocarditis,Endocarditis, Loefflers,Eosinophilic Leukemia,Eosinophilic Leukemias,Hypereosinophilic Syndromes,Hypereosinophilic Syndromes, Idiopathic,Idiopathic Hypereosinophilic Syndromes,Leukemias, Eosinophilic,Loefflers Endocarditis,Syndrome, Hypereosinophilic,Syndrome, Idiopathic Hypereosinophilic,Syndromes, Hypereosinophilic,Syndromes, Idiopathic Hypereosinophilic

Related Publications

A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome.
March 2001, The British journal of dermatology,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Skin lesions as the only manifestation of the hypereosinophilic syndrome.
April 1997, The British journal of dermatology,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Skin lesions as the first manifestation of the hypereosinophilic syndrome.
May 1982, Clinical and experimental dermatology,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Pneumothorax as the initial manifestation of idiopathic hypereosinophilic syndrome.
November 2014, The Annals of thoracic surgery,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Eosinophilic vasculitis as a manifestation of idiopathic hypereosinophilic syndrome.
April 2022, The Journal of dermatology,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Eosinophilic pleural effusion as a manifestation of idiopathic hypereosinophilic syndrome.
October 2016, Archivos de bronconeumologia,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Eosinophilic cellulitis as a cutaneous manifestation of idiopathic hypereosinophilic syndrome.
December 2003, Journal of the American Academy of Dermatology,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
Hypereosinophilic dermatitis: generalised lichenification and gyrate erythema as the sole manifestation of idiopathic hypereosinophilic syndrome.
October 2019, BMJ case reports,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
[Idiopathic hypereosinophilic syndrome. Enterocolitis--a rare manifestation].
August 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A Offidani, and M L Bernardini, and O Simonetti, and C Simoncini, and M Giangiacomi, and G Bossi
A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis.
January 2002, Digestive diseases and sciences,
Copied contents to your clipboard!